News

Astrellas and KI researchers stand together in Astrellas Looby

MIT welcomes Astellas to the BioConvergence Cancer Alliance 

May 15, 2026

The Koch Institute announced that Astellas Pharma has joined the BioConvergence Cancer Alliance. As a member of the alliance, Astellas will closely engage with a thriving research community at the Koch Institute and flagship initiatives, as well as explore opportunities for formal scientific collaborations with faculty members at the Institute.

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Showing 91–100 of 735 stories

Meet the 2025 Amon Award Winners

MIT Koch Institute

August 12, 2025

The Koch Institute at MIT is pleased to announce the winners of the 2025 Angelika Amon Young Scientist Award, Sourav Ghosh and Kotaro Tomuro. The prize was established in 2021 to recognize graduate students in the life sciences or biomedical research from institutions outside the United States who embody Dr. Amon’s infectious enthusiasm for discovery science.

Louis DeRidder receives Inventor Prize from NAI

National Academy of Inventors

August 10, 2025

Congratulations to Louis DeRidder on being recognized by the National Academy of Inventors with the Dr. Barry Bercu Biomedical University Inventor Prize! DeRidder wins the prize for for his work on CLAUDIA, developed as part of a Bridge Project team led by Robert Langer, Giovanni Traverso, and Dana-Farber Cancer Institute's Doug Rubinson. This new closed-loop drug delivery system allows personalized and more accurate chemotherapy drug dosing.

Alumni Innovators

Forbes

August 7, 2025

At Strand Therapeutics, Jake Becraft and Tasuku Kitada are moving research with roots in the Weiss and Irvine labs toward the clinic, by creating mRNA therapies that instruct tumors to produce signals that make them visible to the immune system.

Tracing cancer's family tree

MIT News

July 30, 2025

Jonathan Weissman and his group have developed PEtracer, a tool that reconstructs cellular family trees and maps their locations within tissues. Published in Science, the research reveals how tumors grow and evolve over time, showing how both intrinsic cell traits and environmental factors shape tumor progression.

AI Brings Hidden Cells Into Focus

MIT News

July 11, 2025

A Shalek lab research collaboration led by postdoc Bokai Zhu has developed CellLENS (Cell Local Environment and Neighborhood Scan), an AI-powered approach that uncovers hidden cell subtypes influencing immune responses in cancer. Published in Nature Immunology, the study reveals patterns of cell heterogeneity that could advance cancer immunotherapy.

Can your liver analytic multi-task?

MIT News

June 30, 2025

A research team, led by Jonathan Weissman, has developed Perturb-Multi, a new approach that simultaneously measures different downstream effects of genetic changes—including overall gene expression patterns, protein distribution, and cell structure—in intact liver tissue.  

Whitney Henry named HHMI Freeman Hrabowski Scholar

Howard Hughes Medical Institute

June 20, 2025

Whitney Henry has been named a 2025 HHMI Freeman Hrabowski Scholar. Her work focuses on ferroptosis, a form of regulated cell death with implications for cancer therapy. The award recognizes early-career faculty for exceptional research and commitment to advancing diversity in science. 

Strong and Stretchy

MIT News

June 4, 2025

A 2025 Koch Institute Image Awards winner, research lead by James U. Surjadi and Bastien F. G. Aymon reveals a 3D-printable metamaterial—inspired by collagen’s strength and flexibility—that offers new ways to study how cancer cells migrate through tissue.  

Density detector

MIT News

May 30, 2025

Scott Manalis, collaborating with Dana-Farber Cancer Institute's Keith Ligon, has developed a technique to measure single-cell density for predicting whether immunotherapies will work in a patient or how a tumor will respond to drug treatment. This method, detailed in Nature Biomedical Engineering, originated as a project funded in part by the MIT Center for Precision Cancer Medicine.   

Bravo: smarter breast cancer scans

NBC Boston

May 30, 2025

Recently featured on NBC Boston, Cima Lab alum Canan Dagdeviren is developing wearable ultrasound technology for early breast cancer detection. The device, embedded in a bra, delivers results for less than $3 and sends data to the cloud and the patient’s doctor, offering a valuable tool for diagnosing early stage tumors in high-risk patients.